5 semaglutide 5mg | Lyophilized Powder Multi-Dose Vial People are overdosing on injectable
Description
GLP-1 therapy is not for everyone which is why every MedLounge program begins with a full medical evaluation
It helps control blood sugar levels by stimulating insulin secretion, inhibiting glucagon release, and slowing gastric emptying
Patients do not know they have diabetic gastroparesis until they are put on a glucagon-like peptide 1 (GLP-1) receptor agonist such as semaglutide to manage their blood glucose
Mild to moderate nausea and constipation can often be managed with dietary adjustments, hydration, and timebut your provider should guide any dose modifications or medication changes
Learn more*
